Settlement - Purchase of shares
02 Junio 2023 - 4:52AM
Settlement - Purchase of shares
2 June 2023
Announcement no. 33
Inside information
Settlement - purchase of
shares
In connection with completion of Pharma Equity
Group A/S' (the "Company") purchase of Reponex Pharmaceuticals A/S
("Reponex"), the new shares issued to former larger shareholders in
Reponex were subject to a lock-up undertaking (the "Lock-Up
Undertaking").
As a shareholder by mistake, and without having
obtained consent from the Company, has divested shares in the
Company in violation of the Lock-Up Undertaking, such shareholder
has, as a consequence, undertaken towards the Company and the
Company's board of directors to buy back in the market minimum
6,795,163 shares (with a nominal value of DKK 1.0 each). The share
purchase shall be completed no later than on 21 June 2023.
For further information, please
contact:
Thomas Kaas Selsø, CEO of Pharma Equity Group
A/S, phone: 40 22 21 14
Peter M. Eriksen, Chair of the Board of
Directors of Pharma Equity Group A/S, phone: 51 99 66 00.
Pharma Equity Group A/s (LSE:0REU)
Gráfica de Acción Histórica
De Abr 2024 a May 2024
Pharma Equity Group A/s (LSE:0REU)
Gráfica de Acción Histórica
De May 2023 a May 2024